Astria Therapeutics, Inc. ATXS

Full chart Compare
Set alert

Price alert · ATXS

All alert types
12.58 USD 0.00 (+0.00%)

At closeJan 23, 2026, 4:00 PM EST

12.58 0.00 0.00%

After hours · Jan 23, 4:00 PM ET

12.58 Day range 12.58

52-week range unavailable

YTD
-3.90%
1 year
+66.62%

Revenue & Expenses

Other Income → Expenses: $192.00KExpenses → Selling, General & Admin: $8.91MExpenses → Research & Development: $18.68MExpenses → Interest Expense: $462.00KGross Profit → Expenses: $500.00KRevenue → Gross Profit: $500.00KNet Loss → Expenses: $27.36MOther Income$192.00KGross Profit$500.00KNet Loss$27.36MExpenses$28.06MSelling, General & Admin$8.91MResearch & Development$18.68MInterest Expense$462.00KRevenue$500.00K

Latest period ending Dec 31, 2024 · select a line to chart its full history

ATXS annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-111.56M-83.03M-53.50M-194.98M-37.44M
-94.26M-72.89M-51.83M-194.91M-37.30M
-1.68-2.42-3.55-24.58-12.20
ATXS annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
59.82M175.53M20.52M86.51M24.93M
342.36M254.67M230.63M127.51M47.46M
23.10M11.55M9.42M5.20M6.79M
5.35M329.00K939.00K365.00K1.05M
319.26M243.12M221.22M122.31M40.67M
ATXS annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-81.21M-68.44M-43.53M-30.15M-32.48M
-191.86M135.05M-167.13M-12.55M6.30M
157.20M88.40M144.72M104.28M40.86M
-325.00K-25.00K-91.00K-21.00K-33.00K
-115.87M155.00M-65.94M61.58M14.68M